Browse
Submit Data
Databases
API
Help

Dataset Information

25 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Monoclinic modification of 1,1,3,3,5,5-hexa-methyl-cyclo-1,3,5-tris-tannathiane.

ABSTRACT: The asymmetric unit of the title compound, [Sn(3)(CH(3))(6)S(3)], contains two molecules with twist-boat conformations. There are intermolecular S?H (2.929?Å), S?S (3.433?Å), S?C (3.465?Å) and C?H (2.898?Å) inter-actions in addition to prominent intermolecular Sn?S inter-actions of 3.692 and 3.769?Å.

SUBMITTER: Singh N

PROVIDER: S-EPMC2915068 | biostudies-literature | 2007 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Monoclinic modification of 1,1,3,3,5,5-hexa-methyl-cyclo-1,3,5-tris-tannathiane.

Singh Nanhai N Kumar Abhinav A Molloy Kieran C KC Kociok-Köhn G G

Acta crystallographica. Section E, Structure reports online 20071206 Pt 1

The asymmetric unit of the title compound, [Sn(3)(CH(3))(6)S(3)], contains two molecules with twist-boat conformations. There are intermolecular S⋯H (2.929 Å), S⋯S (3.433 Å), S⋯C (3.465 Å) and C⋯H (2.898 Å) inter-actions in addition to prominent intermolecular Sn⋯S inter-actions of 3.692 and 3.769 Å. ...[more]

PMID: 21200475

Similar Datasets

Second monoclinic modification of cyclo-hexane-1,1-dicarbonitrile.

Project description:In the title compound, C(8)H(10)N(2), the cyclo-hexane ring adopts a chair conformation. he crystal structure of the previously reported monoclinic modification have intramolecular CN?CN and C-H?N interactions. These types of interaction are not present in this new modification whose crystal structure is built up by van der Waals interactions.

| S-EPMC3152107 | biostudies-literature

Crystal structure of 2,4,6-tris-(cyclo-hex-yloxy)-1,3,5-triazine.

Project description:The title compound, C21H33N3O3, is a tri-substituted cyclo-hex-yloxy triazine. In the crystal, the triazine rings form (C3i-PU) Piedfort units. The inter-centroid distance of the π-π inter-action involving the triazine rings is 3.3914 (10) Å. In the crystal, mol-ecules are linked by C-H⋯O hydrogen bonds, forming ribbons propagating along [1-10]. There are also weak C-H⋯N and C-H⋯O contacts present, linking inversion-related ribbons, forming a three-dimensional structure.

| S-EPMC4645094 | biostudies-literature

Crystal structure and Hirshfeld surface analysis of 3,3',3''-[(1,3,5-triazine-2,4,6-tri-yl)tris-(-oxy)]tris-(5,5-di-methyl-cyclo-hex-2-en-1-one).

Project description:The three cyclo-hexenone rings of the title compound, C27H33N3O6, adopt slightly distorted envelope conformations, with the C atom bearing two methyl groups as the flap atom in each case. These cyclo-hexenone mean planes form dihedral angles of 87.41?(11), 70.73?(11) and 70.47?(11)° with the 1,3,5-triazine ring, while the dihedral angle between the cyclo-hexenone mean planes are 57.52?(12), 23.75?(12) and 53.21?(12)°. In the crystal, mol-ecules are linked via C-H?O hydrogen bonds, forming a three-dimensional network.

| S-EPMC6038646 | biostudies-literature

Hexa-kis-(3-chloro-2-methyl-anilinium) cyclo-hexa-phosphate dihydrate.

Project description:In the organic/inorganic salt hydrate, 6C7H9ClN(+)·P6O18 (6-)·2H2O, the cyclo-hexa-phosphate anion resides on an inversion centre. The asymmetric unit consists of three cations, one half-anion and a water mol-ecule. In the crystal, the water mol-ecules and the [P6O18](6-) anions are linked by O-H⋯O hydrogen bonds, generating infinite layers parallel to the ab plane. These layers are inter-connected by the organic cations through N-H⋯O hydrogen bonds.

| S-EPMC3914095 | biostudies-literature

Tris(1-ethyl-3-methyl-imidazolium) hexa-bromidoeuropate(III).

Project description:The crystal structure of the title compound, (C(6)H(11)N(2))(3)[EuBr(6)], consists of 1-ethyl-3-methyl-imidazolium cations and centrosymmetric octa-hedral hexa-bromido-europate anions. The [EuBr(6)](3-) anions are located at the corners and face-centres of the monoclinic unit cell. Characteristic hydrogen-bonding inter-actions can be observed between the bromide anions and the acidic H atoms of the imidazolium cations.

| S-EPMC2961749 | biostudies-literature

Dilithium hexa-hydroxidostannate(IV) dihydrate, a second monoclinic modification with a layer structure.

Project description:The title compound, Li2[Sn(OH)6]·2H2O, is dimorphic. As for the previously described ?-modification, the title ?-modification crystallizes in the monoclinic system and contains the same primary building units, viz [Sn(OH)6](2-) octa-hedra and [Li(?2-OH)3(H2O)] tetra-hedra. In contrast to the Sn-O bond lengths that are very similar in both modifications, the Li-O bond lengths differ significantly, in particular those involving the water mol-ecule. In the new ?-modification, the primary building units are linked into layers parallel to (010). The [Sn(OH)6](2-) octa-hedra (-1 symmetry) form hexa-gonal nets and the [Li(?2-OH)3(H2O)] tetra-hedra are situated in between, with their apices in an alternating fashion up and down. O-H?O hydrogen bonds between OH groups and water mol-ecules exist within the layers as well as between them.

| S-EPMC3647783 | biostudies-literature

Tris(cis-2-hy-droxy-cyclo-hexane-1,3,5-tri-aminium) hydrogen sulfate octa-chloride dihydrate.

Project description:The 2-hy-droxy-cyclo-hexane-1,3,5-triaminium (= H(3)L(3+)) cation of the title compound, 3C(6)H(18)N(3)O(3+)·8Cl(-)·HSO(4) (-)·2H(2)O, exhibits a cyclo-hexane chair with three equatorial ammonium groups and one axial hy-droxy group in an all-cis configuration. The hydrogen sulfate anion and two water mol-ecules lie on or in proximity to a threefold axis and are disordered. The crystal structure features N-H?Cl and O-H?Cl hydrogen bonds. Three C(3)-symmetric motifs can be identified in the structure: (i) Two chloride ions (on the C(3)-axis) together with three H(3)L(3+) cations constitute an [(H(3)L)(3)Cl(2)](7+) cage. (ii) The lipophilic C(6)H(6)-sides of three H(3)L(3+) cations, which are oriented directly towards the C(3)-axis, generate a lipophilic void. The void is filled with the disordered water mol-ecules and with the disordered part of the hydrogen sulfate ion. The hydrogen atoms of these disordered moieties were not located. (iii) Three H(3)L(3+) cations together with one HSO(4) (-) and three Cl(-) counter-ions form an [(HSO(4))(H(3)L)(3)Cl(3)](5+) cage. Looking along the C(3)-axis, these three motifs are arranged in the order (cage 1)?(lipophilic void)?(cage 2). The crystal studied was found to be a racemic twin.

| S-EPMC3379457 | biostudies-literature

4,4',4''-Tris(2-pyrid-yl)-2,2',2''-[(2,4,6-trimethyl-benzene-1,3,5-tri-yl)tris-(methyl-ene)tris-(sulfanedi-yl)]tripyrimidine.

Project description:The title compound, C(39)H(33)N(9)S(3), features a mesitylene unit substituted with three thio-ether arms. The distances from the center of mesitylene unit to the N atoms of the three pyridine rings in the arms are 10.05?(1), 9.94?(3) and 8.79?(3)?Å. The crystal structure shows weak intra-molecular C-H?N hydrogen bonds.

| S-EPMC2977171 | biostudies-literature

2,2-Bis[3,5-bis-(di-methyl-amino)-phen-yl]-1,1,1,3,3,3-hexa-methyl-tris-ilane.

Project description:The title compound, C26H48N4Si3, was synthesized by the reaction of 2,2-di-chloro-tris-ilane with 3,5-bis-(di-methyl-amino)-phenyl-lithium. In the mol-ecule, the dihedral angle between the benzene rings is 57.57 (7)° and the Si-Si-Si bond angle is 110.08 (2)°. In the crystal, mol-ecules are linked via an SiC-H⋯π(ar-yl) inter-action, forming a chain along the c-axis direction.

| S-EPMC9462273 | biostudies-literature

Tris(N,N-di-methyl-anilinium) hexa-bromido-stannate(IV) bromide.

Project description:In the title compound, (C8H12N)3[SnBr6]Br, the anilinium N atom of one of the three unique cations exhibits flip-flop disorder with an 0.60:0.40 occupancy ratio. In the crystal, N-H⋯Br hydrogen bonds link the N,N-di-methyl-anilinium cations and both Br(-) anions and [SnBr6](2-) dianions into a layered arrangement parallel to (001).

| S-EPMC3684876 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data